Certara Inc (NAS:CERT)
$ 13.29 0.29 (2.23%) Market Cap: 2.14 Bil Enterprise Value: 2.22 Bil PE Ratio: 0 PB Ratio: 2.05 GF Score: 83/100

Certara Inc at Bank of America Tech Solutions for Drug Discovery Conference (Virtual) Transcript

Sep 20, 2021 / 11:55AM GMT
Release Date Price: $34.41 (-0.89%)
Michael Leonidovich Ryskin
BofA Securities, Research Division - Associate

Good morning, and thank you for joining us. My name is Mike Ryskin, and I'm on the life science tools and diagnostics team here at Bank of America. We're excited to be hosting our first Tech Solutions for Drug Discovery Conference.

By way of intro, we really see this tech-enabled drug discovery topic as a growing new subsector in public markets, and it's a very exciting opportunity at the intersection of tools technologies, software technologies and computing and biotechnology. The underlying problem that these companies are all trying to address: less efficient R&D at pharma and biotech, lower ROI, falling success rates, higher cost of drugs development. They've all been well characterized and are well understood. But despite years of efforts, we haven't seen significant progress until now.

Using genomics, proteomics and other omics technologies to generate vast amounts of data about underlying human biology and then leveraging AI, machine learning and software algorithms to process these massive data sets

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot